Company / CapEx per Share
MAXCYTE, INC. CapEx per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $0.18
FY2021-FY2025
Trend
-53.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has declined for 3 consecutive years, from $0.18 in FY2022 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 3-year CAGR of -54.9%.
Declined from $0.18 to $0.02 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -54.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- MAXCYTE, INC.'s capex per share has declined for 3 consecutive years.
- In FY2025, capex per share decreased 53.0% year-over-year.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -53.0% |
| FY2024 | $0.04 | -80.3% |
| FY2023 | $0.18 | -1.2% |
| FY2022 | $0.18 | +268.5% |
| FY2021 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026